Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).
NCT00404261
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
132
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Fluticasone/Salmeterol HFA
Sponsor
GlaxoSmithKline